Cardea Technology Inc and Optasia Medical Ltd Announce Plans to Collaborate to Optimize...

Cardea Technology Inc and Optasia Medical Ltd Announce Plans to Collaborate to
Optimize Their Vertebral Fracture Assessment Tools

BOSTON, Massachusetts and CHEADLE, England, August 27 /PRNewswire/ --
Cardea Technology, Inc. and Optasia Medical Ltd., announce plans to
collaborate and configure their software tools for Vertebral Fracture
Assessment, a method for evaluating vertebral fractures from images on bone
densitometers, to exchange information and create reports for the management
of osteoporosis.
Optasia Medical Ltd. has developed SpineAnalyzer(TM), a product that aids
in the identification of vertebral spine deformities by efficiently and
comprehensively annotating spine anatomy. This unique software workflow
solution enables rapid and reproducible assessment of 6-point morphometry,
while simultaneously providing full contours outlining vertebral shape. The
software employs a proprietary statistical model-based image analysis
technique, which uses a simple manual single-point initialization to
automatically segment the lateral vertebrae from T4 to L4. SpineAnalyzer(TM)
is designed to fit seamlessly into the existing workflow of scoring a lateral
spine image.
Cardea Technology develops BoneStation, a web-based software program that
automates the review of VFA and X-Ray scans and the creation of bone density
reports. BoneStation facilitates the secure transmission of DXA scans and
data from a bone densitometer to a central database where scans are instantly
viewed from any computer with internet access. During the scan review in
BoneStation, a physician can incorporate a patient's bone fracture risk
factors into the patient's overall assessment and report.
With new data sharing functions, BoneStation and SpineAnalyzer(TM)
provide physicians with enhanced capability to measure and report on
vertebral spine deformities. After an operator creates a 6-point morphometry
assessment with SpineAnalyzer(TM), it is displayed in the BoneStation
interface and integrated into BoneStation's comprehensive osteoporosis
assessment reports.
For more information and a tour of BoneStation's capabilities, please
visit http://www.bonestation.com. For more information on Optasia Medical and
SpineAnalyzer(TM), please visit http://www.optasiamedical.com.
SpineAnalyzer(TM) is pending FDA approval and is not currently available for
sale in the US.
Contact: Peter Steiger +1-508-405-4392 & Gretchen DeGlopper
+1-877-392-7763 ext 504
SOURCE Cardea Technology Inc. and Optasia Medical Ltd.

Peter Steiger +1-508-405-4392 & Gretchen DeGlopper +1-877-392-7763 ext 504